Percutaneous nephrolithotomy is a specialized urological operation for clearing large and complex upper urinary tract stones. The primary goal of PCNL is complete stone clearance while preserving kidney function and minimizing surgical tissue injury. Clinical practice guidelines from the European Association of Urology (EAU 2023) and the American Urological Association (AUA 2019) establish PCNL as the first-line treatment for renal stones larger than 20 millimeters.

Pre-operative antibiotics are administered. General anesthesia is established. A fine drainage catheter is placed into the ureter via cystoscopy to outline the kidney collecting system. The patient is positioned in either a prone (facing down) or supine (facing up) position. Fluoroscopic or ultrasound guidance directs a needle through the skin into the target kidney calyx. A guide wire is advanced through the needle. The working tract is dilated using rigid or balloon dilators to allow placement of an access sheath. A nephroscope is introduced through the sheath. Ultrasonic, pneumatic, or laser lithotripsy energy breaks the stone. Fragments are removed using grasping instruments and continuous fluid flush. Intraoperative inspection confirms stone clearance. A nephrostomy tube, internal ureteral stent, or tubeless closure is completed based on intraoperative findings.

Evidence-based benefits of PCNL include complete single-stage stone clearance rates of 85% to 95% for complex calculi, immediate relief of urinary obstruction, preservation of long-term renal function, reduction of recurrent stone-related infections, and significantly lower morbidity compared to traditional open kidney surgery.

Hospital stay typically lasts 1 to 3 days. Early walking begins on the first post-operative day. If a kidney drainage tube (nephrostomy tube) is placed, it is usually removed within 24 to 48 hours once urine clears. Strenuous activity and heavy lifting over 10 pounds should be avoided for 2 to 4 weeks. Normal non-strenuous daily activities and desk work can resume within 7 to 14 days. Complete internal tissue healing and urine stabilization occur within 4 to 6 weeks.

PCNL is indicated for large renal calculi (kidney stones greater than 20 mm in diameter), staghorn calculi (stones filling multiple branches of the renal collecting system), lower pole kidney stones larger than 15 mm, cystine or uric acid stones resistant to non-surgical therapy, and calculi within anatomically abnormal kidneys such as horseshoe kidneys.

Patients complete pre-operative non-contrast computed tomography (NCCT) scanning for anatomical mapping. Urine culture testing is mandatory to ensure urine is completely sterile prior to surgery; positive cultures require antibiotic treatment. Coagulation blood tests (PT/INR, aPTT, platelet count) are assessed, and blood-thinning medications (such as aspirin, warfarin, or direct oral anticoagulants) are paused under clinician supervision, typically 5 to 7 days before surgery. Fasting from solid food and liquid begins 8 hours prior to general anesthesia. Pre-anesthesia medical clearance is performed for cardiac and pulmonary safety.

Common and mild risks include visible blood in the urine (hematuria), transient flank soreness, mild post-operative fever, and minor skin tube site leakage. Less common risks include urinary tract infection, stent-related bladder irritation, and minor prolonged fluid collection. Rare but serious risks include severe renal bleeding requiring blood transfusion (less than 5%) or arterial embolization (less than 1-2%), adjacent organ injury such as pleural puncture or pneumothorax (1-3%), bowel injury (less than 0.5%), severe infection or sepsis (1-2%), and emergency open operation or renal loss (rare).

The clinical care pathway begins with a pre-operative evaluation that includes non-contrast computed tomography imaging and urine culture clearance. On the day of surgery, general anesthesia is administered, and access to the kidney is established using image-guided needle placement. The surgeon dilates a small channel, inserts an endoscope, fragments the stone, and evacuates the pieces. Following surgery, patients stay in the hospital for 1 to 3 days with close monitoring of urine output and drain sites. Full recovery and return to normal activities typically occur within 2 to 4 weeks, with a follow-up imaging scan at 4 to 6 weeks to confirm complete stone clearance.